ANGLE Focused On Market Adoption For Parsortix As Loss Widens
30th Jan 2014 11:28
LONDON (Alliance News) - ANGLE PLC said Thursday that it was focused on establishing widespread market adoption for its Parsortix cell separation system following marketing authorisation in Europe, as its pretax loss widened in the half-year ended October 31. Parsortix is a cell separation Read More